Citation only
via OpenAlex
Beneficial effects of the senolytic cocktail, dasatinib and quercetin, on age-related vascular and metabolic dysfunction are lost in mice lacking T and B cells
Md Shariful Islam, Md Torikul Islam, Shelby Hall, Anthony J. Donato, Lisa A. Lesniewski
Physiology · 2025
Abstract
Aging is an independent risk factor of arterial and metabolic dysfunction, although the mechanisms remain incompletely understood. Cellular senescence(definition), a persistent cell cycle arrest, accompanies age-related arterial and metabolic dysfunction. Reducing senescence burden after treatment with the senolytic cocktail, dasatinib and quercetin (D&Q), improves age-related arterial and metabolic dysfunction, although the tissues and/or cell types involved in these beneficial effects are unknown. At steady state, T cells play a critical role in eliminating senescent cells and suppressing inflammation. Likewise, evidence exist that aged T cells promote multiorgan aging and age-related systemic dysfunction. Previously, we have shown that T lymphocytes promote age-related arterial and metabolic dysfunction. Together, these raise a key question whether the beneficial effects of senolytic drugs are mediated through aged T cells. Here, we sought to test the hypothesis that T cells mediate the beneficial effects of senolysis in old mice. To test this hypothesis, 27-mo. Rag-/- mice (D&Q: n = 4, vehicle: n = 3), that lack functional T and B lymphocytes, were treated with D (5 mg/kg) & Q (50 mg/kg) for 3 consecutive days in every 15 days for 3 months. Arterial stiffness, assessed by aortic pulse wave velocity, was higher in D&Q (n = 4) compared to vehicle (n = 3) treated old RAG-/- mice. (P = 0.03). Likewise, endothelium-dependent dilation (EDD) to acetylcholine, assessed using pressure myography, was lower in isolated mesenteric arteries of the D&Q treated old RAG-/- mice compared to vehicle controls (P = 0.001). Differences in vasodilation between the treatment groups were abolished after L-NAME incubation, indicating that the impairment in EDD resulted from lower nitric oxide bioavailability in the D&Q treated RAG-/- mice (P = 0.73). Glucose (2 g/kg body mass, IP, GTT) and insulin (1 U/kg body mass, IP, ITT) tolerance tests were performed in fasted (4-6 hr) mice to assess systemic metabolic function. There were no differences in glucose or insulin tolerance between the D&Q (n = 4) and vehicle (n = 3) treated old RAG-/- mice(P = 0.65 & 0.33). These results suggest that the beneficial effects of senolytic treatment in old mice may require T and/or B cells. Future studies could employ the adoptive transfer of T cells from control mice to Rag-/- mice as well as antibody mediated T cell depletion in combination with senolytic treatment to explore the necessity of T cells in the beneficial effects of senolysis. NIA. Grant Numbers: R01 AG048366, R01 AG050238, R01 AG060395U.S. Department of Veterans Affairs. Grant Numbers: I01 BX002151, I01 BX004492 This abstract was presented at the American Physiology Summit 2025 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1152/physiol.2025.40.s1.1661
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Islam, M.S., Islam, M.T., Hall, S., Donato, A.J., & Lesniewski, L.A. (2025). Beneficial effects of the senolytic cocktail, dasatinib and quercetin, on age-related vascular and metabolic dysfunction are lost in mice lacking T and B cells. <em>Physiology</em>. https://doi.org/10.1152/physiol.2025.40.s1.1661
Vancouver
Islam MS, Islam MT, Hall S, Donato AJ, Lesniewski LA. Beneficial effects of the senolytic cocktail, dasatinib and quercetin, on age-related vascular and metabolic dysfunction are lost in mice lacking T and B cells. Physiology. 2025. doi:10.1152/physiol.2025.40.s1.1661.
BibTeX
@article{md2025Benefi,
title = {Beneficial effects of the senolytic cocktail, dasatinib and quercetin, on age-related vascular and metabolic dysfunction are lost in mice lacking T and B cells},
author = {Md Shariful Islam and Md Torikul Islam and Shelby Hall and Anthony J. Donato and Lisa A. Lesniewski},
journal = {Physiology},
year = {2025},
doi = {10.1152/physiol.2025.40.s1.1661},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Arteriosclerosis Thrombosis and Vascular Biology 2026
Citation only
Abstract Thu073: Senolytic drugs, dasatinib and quercetin, ameliorate age- and obesity-related metabolic and arterial dysfunction
Frontiers in Cell and Developmental Biology 2020
Open access · CC-BY
The Senolytic Drug Navitoclax (ABT-263) Causes Trabecular Bone Loss and Impaired Osteoprogenitor Function in Aged Mice
Nature Aging 2024
Open access · CC-BY
Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction
The FASEB Journal 2021
Citation only
Senolytic Drugs, Dasatinib and Quercetin, Attenuate Adipose Tissue T Lymphocyte Infiltration and Improve Metabolic Function in Old Mice
Innovation in Aging 2022
Open access · CC-BY
ORALLY ACTIVE, CLINICALLY TRANSLATABLE SENOLYTICS RESTORE Α-KLOTHO IN MICE AND HUMANS
Nature Aging 2024
Open access · CC-BY